Abbott reports few adverse events in drug-coated stent study

05/21/2009 | CNNMoney

Abbott Laboratories said patients who received its Xience drug-eluting stent had few instances of repeat procedures or major cardiac events during a one-year study on more than 2,000 patients outside the U.S. The findings are similar to results from two clinical trials that helped Abbott secure marketing approval for the device in the U.S. and Europe.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX